Delivery Order SPE2DB20D2001-SPE2DB24FM29U
- Not listed
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of UROCIT-K ER 15 MEQ TABLET UU 100S, a pharmaceutical product, with a ceiling value of $2,877.48 and an ultimate completion date of November 20, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,524.02 and an ultimate completion date of March 4, 2025. It is a firm fixed-price contract for the supply of UROCIT-K SR 10 MEQ TABLET. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This federal contract award, SPE2DB22D3004|SPE2DB25FPK54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,087.20, is for the delivery of UROCIT-K SR 10 MEQ TABLET UU 100S, a medical product. This is a firm fixed-price delivery order contract with a completion date of February 6, 2025. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp is...
- This federal contract award, with a value of $2,811.31, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of UROCIT-K ER 15 MEQ tablets, a medication used to treat various medical conditions. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of UROCIT-K SR 10 MEQ TABLET UU 100S. The contract, valued at $1,252.34, is a firm fixed-price delivery order with a completion date of July 29, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,699.30 firm fixed-price delivery order is for the supply of UROCIT-K SR 10 MEQ tablets, a medical product used in the treatment of various conditions. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Potassium Citrate ER 15 MEQ tablets. The $8,129.98 firm fixed-price delivery order was issued under an existing Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a...
- The Defense Logistics Agency Troop Support Medical awarded a $2,244.23 firm fixed price delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division. The contract is to provide 4561416280 UROCIT-K SR 10 MEQ TABLET UU 100S. The place of performance is Conshohocken, Pennsylvania. The period of performance is July 6, 2023 through July 7, 2023. No major subcontractors or set aside designations were identified. The Defense Logistics Agency Troop Support Medical supports the...
- This federal contract award, with a unique identifier of SPE2DB20D1050|SPE2DB25FH46C, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order, is for the supply of Potassium Citrate ER 10 MEQ TB UU 100S, a pharmaceutical product. The contract has a firm fixed price and a ceiling value of $1,100.74, with an ultimate completion date of January 24, 2025. The...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,214.13, is for the delivery of Potassium Citrate ER 10 MEQ tablets. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a...
- SPE2DB20D2001Indefinite Delivery Contract
- SPE2DB20D2001-SPE2DB24FM29UDelivery Order
This federal contract award, with ID SPE2DB20D2001|SPE2DB24FM29U, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of UROCIT-K ER 15 MEQ TABLET UU 100S, a pharmaceutical product, with a ceiling value of $2,068.60 and a completion date of November 3, 2023. The contract is a Delivery Order under a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp is the prime contractor for this award and holds several Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued at $999,999,999 and $750,000 respectively, for providing a comprehensive range of pharmaceutical products and medical supplies to support federal healthcare programs. This specific award was not designated with a set-aside requirement, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 11/2/23 |